血管镜观察药物洗脱支架置入后支架表面内膜覆盖

上传人:仙*** 文档编号:243942423 上传时间:2024-10-01 格式:PPT 页数:21 大小:2.28MB
返回 下载 相关 举报
血管镜观察药物洗脱支架置入后支架表面内膜覆盖_第1页
第1页 / 共21页
血管镜观察药物洗脱支架置入后支架表面内膜覆盖_第2页
第2页 / 共21页
血管镜观察药物洗脱支架置入后支架表面内膜覆盖_第3页
第3页 / 共21页
点击查看更多>>
资源描述
Click to edit Master title style,Click to edit Master text styles,Second level,Third level,Fourth level,Fifth level,Click to edit Master title style,Click to edit Master text styles,Second level,Third level,Fourth level,Fifth level,Angioscopic Findings of Neointimal Coverage after Drug Eluting Stent Implantation,Shinsuke Nanto,M.D.,PhD.,Department of Advanced Cardiovascular Therapeutics,Osaka University Graduate School of Medicine,Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy,McFadden EP,Serryus PW et al.Lancet 2004,On 442 days of DES implantation,the patient developed AMI one week after aspirin was discontinued because of surgical therapy of colon carcinoma.,Pre procedure,Stent implantation,Post procedure,Late stent thrombosis,Factors of Stent Thrombosis,Coronary blood flow,Multiple stenting,Procedure Related Factors,Morphometric abnormalities,(Underexpansion,Asymmetry?),Molphologic abnormalities,(Dissection,Incomplete apposition,Thrombus,Tissue protrusion),Mechanical vessel injury,Anti-thrombotic therapy,Biocompatibility,Patient/Lesion factors,Vessel size,Lesion length,Acute coronary syndrome,Plaque characteristics,Local plt/coagulation activity,Left ventricular function,Resistance for drugs,Stent Thrombogenisity,Material,Designs,Surface coating,Adjunctive therapeutic agents,(drug,Radiation),Honda Y and Fitzgerald PJ.Circulation 2003;108.,Angioscopic Findings of Neointimal Coverage after Drug Eluting Stent Implantation,Coronary angioscply,Vecmova NEO,(FiberTech,Tokyo,Japan),Classification of Angioscopic Findings,Grade 0,Grade 1,Grade 2,Grade,Grade 0,:struts were exposed similarly to the time of implantation,Grade 1,:struts were covered,but not embedded,Grade 2,:struts were embedded by the neo-intima,but translucency seen,Grade 3,:struts were fully embedded and invisible by angioscopy,Kotani J,Awata M,Nanto S,et al.JACC.2006,Neointimal Coverage Grades,3 to 6 Months After Stent Implantation,0,25,50,75,100,Bare-Metal Stent(n=22),(%),100,75,50,25,0,Incomplete coverage,Sirolimus-Eluting Stent(n=15),Complete coverage,Grade 3,Grade 2,Grade 1,Grade 0,Kotani J,Awata M,Nanto S,et,al.JACC.2006,Representative Cases:BMS vs.SES,Bare-metal stent(BMS)Sirolimus-eluting stent(SES),(Grade 3)(Grade 1),Stent:Cypher 3.518mm,Location:RCA mid,3.7 months f-up,Stent:Bx Velocity 3.523mm,Location:LAD mid,2.7 months f-up,A Case implanted both BMS and DES,Follow up 3.7 months,Bx,Verocity 3.0,18,59 y.o.female,Cypher 3.5,18,12 months,24 months,months,Changes in Neointimal Coverage Grade,Awata M,Kotani J,Nanto S et al.Circulation.2007,Comparison of Angioscopic FindingsSES versus PES at 8 Months,Thirty,PES,were angioscopically compared with 36,SES,.,Intra-and inter-stent heterogeneinty of neointimal coverage were more common in PES.,Incidence of thrombi and yellow plaques were similar between the two groups.,Awata M,Nanto S et al.JACC Cardiol Intv 2009,Neointimal Coverage Grades at 8 months,PES(n=30),SES(n=36),Grade 0,Grade 1,Grade 2,Grade 3,PES vs.SES:p=0.002 by,2,test,test,(%),Awata M,Nanto S et al.JACC Cardiol Intv,2009,Homogeneous,Heterogeneity of Neointimal Coverage Grades,Awata M,Nanto S et al.JACC Cardiol Intv 2009,PES vs.SES:p=0.0006 by,2,test,Heterogeneity,of 1 grade,PES,(n=30),SES,(n=36),Heterogeneous,53%,47%,26%,48%,26%,Homogeneity,Heterogeneity,of 2 grade,74%,Comparison of Angioscopic FindingsSES versus ZES at 8 Months,Awata M,Nanto,S,et al.JACC.2008,Cypher 3.523mm,Endeavor 3.523mm,Neointimal,Coverage,Grades,at 8 months,(%),Awata M,Nanto S,et al.JACC.2008,In-stent ate loss,-SES=0.07 0.18mm,-ZES=0.51 0.17mm,(,p0.0001,),Incidence of Thrombi and Yellow plaques,(n=14),(n=16),P=0.2,(n=14),(n=16),P=0.004,Thrombi,Yellow plaques,Angioscopic Findings ZES vs.SES,8 mo.after implantation,11 mo.after implantation,Results of ENDEAVOR-III,Patient Frequency Distributions,of In-segment Late Loss,0.13,0.32,0.34,0.44,Results of ENDEAVOR-III,Patient Frequency Distributions,of In-segment Late Loss,0.13,0.32,0.34,0.44,The Ideal DES Should Have,Optimal Late Loss with Narrow Distributions,0.13,0.32,0.34,0.44,Ideal DES,Summary,Angiographic findings of DES revealed,Prolonged delayed growth of neointima,Poor but homogenous covering over SES,Heterogeneous luminal surface of PES,White and homogenous appearance in patients treated with ZES:,Basically grade 3 neoinitma,A few yellow plaques and thrombi,Take Home Massages,New Concept for Next-generation DES,Considering the risk of stent thrombosis due to incomplete neointimal coverage,it is preferable for DES to have sufficient neointimal volume with homogeneous coverage.,Optimal late loss with homogeneous coverage,may be desirable for adequate,endothelial,healing following stenting.,
展开阅读全文
相关资源
正为您匹配相似的精品文档
相关搜索

最新文档


当前位置:首页 > 管理文书 > 施工组织


copyright@ 2023-2025  zhuangpeitu.com 装配图网版权所有   联系电话:18123376007

备案号:ICP2024067431-1 川公网安备51140202000466号


本站为文档C2C交易模式,即用户上传的文档直接被用户下载,本站只是中间服务平台,本站所有文档下载所得的收益归上传人(含作者)所有。装配图网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对上载内容本身不做任何修改或编辑。若文档所含内容侵犯了您的版权或隐私,请立即通知装配图网,我们立即给予删除!